Current status of ischemia and reperfusion injury in the liver

Transplantation Reviews

Volumn 14, Issue 2, 2000, Pages 106-126

  Farmer, Douglas G ^a   Amersi, Farin ^a   Kupiec Weglinski, Jerzy ^a   Busuttil, Ronald W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001443254     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1053/tr.2000.4651     Document Type: Article

References (235)

1. Belzer FO, Southard JH: Principles of solid-organ preservation by cold storage. Transplantation 1988, 45:673
2. Wall WJ, Calne RY, Herbertson BM, et al: Simple hypothermic preservation for transporting human livers long distances for transplantation. Report of 12 cases. Transplantation 1977, 23:210
3. Moberg AW, Santiago EA, Mason RV, et al: Transportable organ perfusion system for kidney preservation. Lancet 1971, 2:1403
4. Collins GM, Bravo-Shugarman M, Terasaki PI: Kidney preservation for transportation: Initial perfusion and 30 hours ice storage. Lancet 1969, 2:1219
5. Dreikorn K, Horsch R, Rohl L: 48- to 96-Hour preservation of canine kidneys by initial perfusion and hypothermic storage using the Euro-Collins solution. Eur Urol 1980, 6:221
6. Benichou J, Halgrimson CG, Weil R, et al: Canine and human liver preservation for 6 to 18 hours by cold infusion. Transplantation 1977, 24:407
7. Jamieson NV, Sundgerg R, Lindell S, et al: Successful 24- to 30-hour preservation of the canine liver: A preliminary report. Transplant Proc 1988, 20(suppl 1):945
8. Kalayoglu M, Sollinger HW, Stratta RJ, et al: Extended preservation of the liver for clinical transplantation. Lancet 1988, 1:617
9. Todo S, Nery J, Yanaga K, et al: Extended preservation of human liver grafts with UW solution. JAMA 1989, 261:711
10. McKeown CM, Edwards V, Phillips MJ, et al: Sinusoidal lining cell damage: The critical injury in cold preservation of liver allografts in the rat. Transplantation 1988, 46:178
11. Gao W, Bentley RC, Madden JF, et al: Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. Hepatology 1998, 27:1652
12. Caldwell-Kenkel JC, Thurman RG, Lemasters JJ: Selective loss of nonparenchymal cell viability after cold ischemic storage of rat livers. Transplantation 1988, 45:834
13. Caldwell-Kenkel JC, Currin RT, Tanaka Y, et al: Reperfusion injury to endothelial cells following cold ischemic storage of rat livers. Hepatology 1989, 10:292
14. Ikeda T, Yanaga K, Kishikawa K, et al: Ischemic injury in liver transplantation: Difference in injury sites between warm and cold ischemia in rats. Hepatology 1992, 16:454
15. Manjo G, Joris I: Apoptosis, oncosis, and necrosis: An overview of cell death. Am J Pathol 1995, 146:3
16. Bernardi P, Scorrano L, Colonna R, et al: Mitochondria and cell death: Mechanistic aspects and methodological issues. Eur J Biochem 1999, 264:687
17. Sasaki H, Matsuno T, Tanaka N, et al: Activation of apoptosis during the reperfusion phase after rat liver ischemia. Transplant Proc 1996, 28:1908
18. Saido TC, Sorimachi H, Suzuki K: Calpain: New perspectives in molecular diversity and physiological-pathological involvement. FASEB J 1994, 8:814
19. Sarin A, Clerici M, Blatt SP, et al: Inhibition of activation-induced programmed cell death and restoration of defective immune response of HIV+ donors by cysteine protease inhibitors. J Immunol 1994, 153:862
20. Kohli V, Gao W, Camargo CA Jr, et al: Calpain is a mediator of preservation-reperfusion injury in rat liver transplantation. Proc Natl Acad Sci U S A 1997, 94:9354
21. Xia ZF, Horton JW, Zhao PY, et al: Effects of ischemia on intracellular sodium and phosphates in the in vivo rat liver. J Appl Physiol 1996, 81:1395
22. Walsh TR, Rao PN, Makowka L, et al: Lipid peroxidation is a nonparenchymal cell event with reperfusion after prolonged liver ischemia. J Surg Res 1990, 49:18
23. Marubayashi S, Takenaka M, Dohi K, et al: Adenine nucleotide metabolism during hepatic ischemia and subsequent blood reflow periods and its relation to organ viability. Transplantation 1980, 30:294
24. Saiki S, Yamaguchi K, Chijiiwa K, et al: Phosphoenolpyruvate prevents the decline in hepatic ATP and energy charge after ischemia and reperfusion injury in rats. J Surg Res 1997, 73:59
25. Marubayashi S, Dohi K, Ezaki H, et al: Preservation of ischemic rat liver mitochondrial functions and liver viability with CoQ10. Surgery 1982, 91:631
26. Lemasters JJ, Nieminen AL, Qian T, et al: The mitochondrial permeability transition in toxic, hypoxic and reperfusion injury. Mol Cell Biochem 1997, 174:159
27. Sammut IA, Thorniley MS, Simpkin S, et al: Impairment of hepatic mitochondrial respiratory function following storage and orthotopic transplantation of rat livers. Cryobiology 1998, 36:49
28. Elimadi A, Settaf A, Morin D, et al: Trimetazidine counter-acts the hepatic injury associated with ischemia-reperfusion by preserving mitochondrial function. J Pharmacol Exp Ther 1998, 286:23
29. Tomita I, Sawa M, Munakata T, et al: The beneficial effect of dibutyryl cyclic adenosine monophosphate on warm ischemic injury of the rat liver induced by cardiac arrest. Transplantation 1996, 62:1673
30. Teramoto K, Bowers JL, Kruskal JB, et al: Hepatic microcirculatory changes after reperfusion in fatty and normal liver transplantation in the rat. Transplantation 1993, 56:1076
31. Vollmar B, Glasz J, Leiderer R, et al: Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. Am J Pathol 1994, 145:1421
32. Lim SP, Andrews FJ, Christophi C, et al: Microvascular changes in liver after ischemia-reperfusion injury: Protection with misoprostol. Dig Dis Sci 1994, 39:1683
33. Ames A III, Wright RL, Kowada M, et al: Cerebral ischemia. II. The no-reflow phenomenon. Am J Pathol 1969, 52:437
34. Kloner RA, Ganote CE, Jennings RB: The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974, 54:1496
35. Schmid-Schonbein GW: Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation. Fed Proc 1987, 46:2397
36. Vollmar B, Menger MD, Glasz J, et al: Impact of leukocyte-endothelial cell interaction in hepatic ischemia-reperfusion injury. Am J Physiol 1994, 267:G786
37. Hakamada K, Sasaki M, Takahashi K, et al: Sinusoidal flow block after warm ischemia in rats with diet-induced fatty liver. J Surg Res 1997, 70:12
38. Trevisani F, Colantoni A, Caraceni P, et al: The use of donor fatty liver for liver transplantation: A challenge or a quagmire? J Hepatol 1996, 24:114
39. Anthuber M, Farkas S, Rihl M, et al: Angiotensin-converting enzyme inhibition by enalapril: A novel approach to reduce ischemia/reperfusion damage after experimental liver transplantation. Hepatology 1997, 25:648
40. Chavez-Cartaya RE, Pino DeSola G, Ramirez-Romero P, et al: Ischemia and reperfusion injury of the rat liver: The role of nimodipine. J Surg Res 1996, 60:199
41. Piratvisuth T, Dunne JB, Williams R, et al: Amlodipine improves hepatic hemodynamic and metabolic function in the isolated perfused rat liver after sequential cold and warm ischemia. Transplantation 1995, 60:23
42. Karwinski W, Garcia R, Helton WS: Protective effects of the calcium channel blocker verapamil on hepatic function following warm ischemia. J Surg Res 1996, 64:150
43. Kishimoto TK, Rothlein R: Integrins, ICAMs, and selectins: Role and regulation of adhesion molecules in neutrophil recruitment to inflammatory sites. Adv Pharmacol 1994, 25:117
44. Springer TA: Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Ann Rev Physiol 1995, 57:827
45. Jaeschke H, Smith CW, Clemens MG, et al: Mechanisms of inflammatory liver injury: Adhesion molecules and cytotoxicity of neutrophils. Toxicol Appl Pharmacol 1996, 139:213
46. Jaeschke H: Cellular adhesion molecules: Regulation and functional significance in the pathogenesis of liver diseases. Am J Physiol 1997, 273:G602
47. Farhood A, McGuire GM, Manning AM, et al: Intercellular adhesion molecule 1 (ICAM-1) expression and its role in neutrophil-induced ischemia-reperfusion injury in rat liver. J Leukoc Biol 1995, 57:368
48. Luscinskas FW, Cybulsky MI, Kiely JM, et al: Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1. J Immunol 1991, 146:1617
49. Thornhill MH, Wellicome SM, Mahiouz DL, et al: Tumor necrosis factor combines with IL-4 or IFN-γ to selectively enhance endothelial cell adhesiveness for T cells. J Immunol 1991, 146:592
50. Masinovsky B, Urdal D, Gallatin WM: IL-4 acts synergistically with IL-1β to promote lymphocyte adhesion to microvascular endothelium by induction of vascular cell adhesion molecule. J Immunol 1990, 145:2886
51. Shito M, Wakabayashi G, Ueda M, et al: Interleukin-1 receptor blockade reduces tumor necrosis factor production, tissue injury, and mortality after hepatic ischemia-reperfusion in the rat. Transplantation 1997, 63:143
52. Shirasugi N, Wakabayashi G, Shimazu M, et al: Upregulation of oxygen-derived free radicals by interleukin-1 in hepatic ischemia/reperfusion injury. Transplantation 1997, 64:1398
53. Rosen SD, Bertozz CR: The selectins and their ligands. Curr Opin Cell Biol 1994, 6:663
54. Davenpeck KL, Gauthier TW, Albertne KH, et al: Role of P-selectin in microvascular leukocyte-endothelial interaction in splanchnic ischemia-reperfusion. Am J Physiol 1994, 267: H622
55. Garcia-Criado FJ, Toledo-Pereyra LH, Lopez-Neblina F, et al: Role of P-selectin in total hepatic ischemia and reperfusion. J Am Coll Surg 1995, 181:327
56. Takada M, Nadeau KC, Shaw GD, et al: The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney: Inhibition by a soluble P-selectin ligand. J Clin Invest 1997, 99:2682
57. Burke J, Zibari GB, Brown MF, et al: Hepatic ischemia-reperfusion injury causes E-selectin upregulation. Transplant Proc 1998, 30:2321
58. Schokes DA, Parfrey NA, Halloran PF: Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation 1990, 49:201
59. Shackleton CR, Ettinger SL, McLoughlin MD, et al: Effect of recovery from ischemic injury on class I and class II MHC antigen expression. Transplantation 1990, 49:641
60. Shackleton CR: Upregulation of major histocompatibility complex expression under ischemic conditions in experimental models. Transplant Proc 1998, 30:4264
61. Wakabayashi H, Miyauchi A, Karasawa Y, et al: Effect of warm ischemia and reperfusion injury on inducing major histocompatibility antigens on hepatocytes and nonparenchymal cells in the rat liver. Transplant Proc 1993, 25:3205
62. Collins T, LaPierre LA, Fiers W, et al: Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro. Proc Natl Acad Sci U S A 1986, 83:446
63. Howard TK, Klintmalm GB, Cofer JB, et al: The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation 1990, 49:103
64. Rosen HR, Martin P, Goss J, et al: Significance of early aminotransferase elevation after liver transplantation. Transplantation 1998, 65:68
65. Shackleton CR, Martin P, Melinek J, et al: Lack of correlation between the magnitude of preservation injury and the incidence of acute rejection, need for OKT3, and conversion to FK506 in cyclosporine-treated primary liver allograft recipients. Transplantation 1995, 60:554
66. Kobayashi H, Nonami T, Kurokawa T, et al: Role of endogenous nitric oxide in ischemia-reperfusion injury in rat liver. J Surg Res 1995, 59:772
67. Peralta C, Hotter G, Closa D, et al: Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: Role of nitric oxide and adenosine. Hepatology 1997, 25:934
68. Yin DP, Sankary HN, Chong AS, et al: Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation 1998, 66:152
69. Pannen BH, Al-Adili F, Bauer M, et al: Role of endothelins and nitric oxide in hepatic reperfusion injury in the rat. Hepatology 1998, 27:755
70. Cottart C-H, Do L, Blanc M-C, et al: Hepatoprotective effect of endogenous nitric oxide during ischemia-reperfusion in the rat. Hepatology 1999, 29:809
71. Shiraishi M, Hiroyasu S, Nagahama M, et al: Role of exogenous L-arginine in hepatic ischemia-reperfusion injury. J Surg Res 1997, 69:429
72. Ferraresso M, Burra P, Cadrobbi R, et al: Protective effect of L-arginine on liver ischemia-reperfusion injury. Transplant Proc 1997, 29:393
73. Nilsson B, Yoshida T, Delbro D, et al: Pretreatment with L-arginine reduces ischemia/reperfusion injury of the liver. Transplant Proc 1997, 29:3111
74. Jones SM, Thurman RG: L-Arginine minimizes reperfusion injury in a low-flow, reflow model of liver perfusion. Hepatology 1996, 24:163
75. Burra P, Chirizzi L, Cadrobbi R, et al: Evaluation of liver function and morphology following ischemia-reperfusion injury in pigs. Transplant Proc 1997, 29:3515
76. Ohmori H, Dhar DK, Nakashima Y, et al: Beneficial effects of FK409, a novel nitric oxide donor, on reperfusion injury of rat liver. Transplantation 1998, 66:579
77. Dhar DK, Yamanoi A, Ohmori H, et al: Modulation of endothelin and nitric oxide: A rational approach to improve canine hepatic microcirculation. Hepatology 1998, 28:782
78. Yanagisawa M, Kurihara H, Kimura S, et al: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988, 332:411
79. Zhang JX, Pegoli W Jr, Clemens MG: Endothelin-1 induces direct vasoconstriction of hepatic sinusoids. Am J Physiol 1994, 266:G624
80. Kawamura E, Yamanaka N, Okamoto E, et al: Response of plasma and tissue endothelin-1 to liver ischemia and its implication in ischemia-reperfusion injury. Hepatology 1995, 21:1138
81. Goto M, Takei Y, Kawano S, et al: Endothelin-1 is involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbances. Hepatology 1994, 19: 675
82. Urakami A, Todo S, Zhu Y, et al: Attenuation of ischemic liver injury by monoclonal anti-endothelin antibody, AwETN40. J Am Coll Surg 1997, 185:358
83. Nakamura S, Nishiyama R, Serizawa A, et al: Hepatic release of endothelin-1 after warm ischemia. Reperfusion injury and its hemodynamic effect. Transplantation 1995, 59:679
84. Mitsuoka H, Suzuki S, Sakaguchi T, et al: Contribution of endothelin-1 to microcirculatory impairment in total hepatic ischemia and reperfusion injury. Transplantation 1999, 67: 514
85. Imakita M, Yamanaka N, Kuroda N, et al: Effects of the endothelin receptor antagonist TAK-044 on hepatocyte element alterations in the ischemic-reperfused liver in beagle dogs. J Hepatol 1998, 28:204
86. Yamanaka N, Takaya Y, Oriyama T, et al: Hepatoprotective effect of a nonselective endothelin receptor antagonist (TAK-044) in the transplanted liver. J Surg Res 1997, 70:156
87. Kitayama Y, Yamanaka N, Kawamura E, et al: Hepatoprotective effect of the endothelin receptor antagonist TAK-044 against ischemia-reperfusion injury in the canine liver. Hepatology 1997, 25:938
88. Snyder F: Chemical and biochemical aspects of platelet-activating factor: A novel class of acetylated ether-linked choline-phospholipids. Med Res Rev 1985, 5:107
89. Zhou W, McCollum MO, Levine BA, et al: Inflammation and platelet-activating factor production during hepatic ischemia/ reperfusion. Hepatology 1992, 16:1236
90. LaPointe DS, Olson MS: Alteration of hepatic tissue spaces by platelet-activating factor and phenylephrine. Hepatology 1989, 9:278
91. Serizawa A, Nakamura S, Suzuki S, et al: Involvement of platelet-activating factor in cytokine production and neutrophil activation after hepatic ischemia-reperfusion. Hepatology 1996, 23:1656
92. Ontell SJ, Makowka L, Trager J, et al: Pharmacologic modulation of experimental postischemic hepatic function. Ann Surg 1989, 209:200
93. Chavez-Cartaya RE, Metcalfe S, Ramirez-Romero P, et al: Rat liver blood flow after ischemia and reperfusion. The effects of the platelet-activating factor antagonist WEB-2170 and of removing circulating leukocytes. Transplantation 1994, 57:1440
94. Seeds MC, Bass DA: Regulation and metabolism of arachidonic acid. Clin Rev Allergy Immunol 1999, 17:5
95. Ernster L: Biochemistry of reoxygenation injury. Crit Care Med 1988, 16:947
96. 2synthetase inhibitor on cold-stored rat liver. Transplantation 1994, 58:768
97. 2 receptor antagonist ONO 3708 on ischemia-reperfusion injury in the dog liver. Surgery 1994, 116:896
98. Richardson PDI, Withrington PG: Liver blood flow. II. Effects of drugs and hormones on liver blood flow. Gastroenterology 1981, 81:356
99. 2 and dexamethasone. J Hepatol 1988, 7:353
100. 2 modulation of superoxide production by human neutrophils. Biochem Biophys Res Commun 1983, 113:506
101. 1. Transplantation 1989, 48:447
102. 1 reduces injury in hepatic allografts following preservation. J Surg Res 1991, 50:595
103. 1 on warm ischemic liver injury. Transplant Proc 1994, 26:2395
104. 1 resuscitates hepatic organic anion transport independent of its hemodynamic effect after warm ischemia. J Surg Res 1997, 68:56
105. 1 incorporated in lipid microspheres, protects injury of the liver caused by warm ischemia reperfusion. Free Radic Biol Med 1996, 21:353
106. 2 analogue, OP-41483. J Am Coll Surg 1998, 187:276
107. 1 protects against ischemia-reperfusion injury of the liver by inhibition of neutrophil adherence to endothelial cells. Transplantation 1997, 64:1514
108. 2) inhibits the formation of platelet thrombi in arterioles and venules of the hamster cheek pouch. Br J Pharmacol 1978, 63:535
109. Jones G, Hurley JV: The effect of prostacyclin on the adhesion of leucocytes to injured vascular endothelium. J Pathol 1984, 142:51
110. Miller TA: Protective effects of prostaglandins against gastric mucosal damage: Current knowledge and proposed mechanisms. Am J Physiol 1983, 245:G601
111. 2 analog on ischemic rat liver. Transplantation 1991, 52:979
112. 2 analogue in complete warm ischemia of the pig liver. Prostanoid release from the reperfused liver. Transplantation 1991, 58:875
113. Anthuber M, Farkas S, Rihl M, et al: Conditioning of liver grafts by donor bolus pretreatment with epoprostenol. Transplantation 1996, 62:13
114. Wang M, Sakon M, Miyoshi H, et al: Prostacyclin analogsuppressed ischemia-reperfusion injury of the rat liver: Evaluation by calpain mu activation. J Surg Res 1997, 73:101
115. Crawford MH, Grover FL, Kolb WP, et al: Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. Circulation 1988, 78:149
116. Weisman HF, Bartow T, Leppo MK, et al: Soluble human complement receptor type 1: In vivo inhibition of complement suppression post-ischemic myocardial inflammation and necrosis. Science 1990, 249:146
117. Rossen RD, Michael LH, Kagiyama A, et al: Mechanism of complement activation after coronary artery occlusion: Evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1Q in vivo. Circ Res 1988, 62:572
118. Vogt W, von Zabern I, Heese D, et al: Generation of an activated form of human C5 (C5-like C5) by oxygen radicals. Immunol Lett 1986/1987, 14:209
119. Jaeschke H, Farhood A, Bautista AP, et al: Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia. Am J Physiol 1993, 264:G801
120. Chavez-Cartaya RE, DeSola GP, Wright L, et al: Regulation of the complement cascade by soluble complement receptor type 1. Protective effect in experimental liver ischemia and reperfusion. Transplantation 1995, 59:1047
121. Decker K: Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 1990, 192:245
122. Caldwell-Kenkel JC, Currin RT, Tanaka Y, et al: Kupffer cell activation and endothelial cell damage after storage of rat livers: Effects of reperfusion. Hepatology 1991, 13:83
123. Jaeschke H, Farhood A: Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol 1991, 260:G355
124. Shiratori Y, Kiriyama H, Fukushi Y, et al: Modulation of ischemia-reperfusion-induced hepatic injury by Kupffer cells. Dig Dis Sci 1994, 39:1265
125. Kukan M, Vajdova K, Horecky J, et al: Effects of blockade of Kupffer cells by gadolinium chloride on hepatobiliary function in cold ischemia-reperfusion injury of rat liver. Hepatology 1997, 26:1250
126. Hisama N, Yamaguchi Y, Ishiko T, et al: Kupffer cell production of cytokine-induced neutrophil chemoattractant following ischemia/reperfusion injury in rats. Hepatology 1996, 24:1193
127. Suzuki S, Nakamura S, Sakaguchi T, et al: Alteration of reticuloendothelial phagocytic function and tumor necrosis factor-alpha production after total hepatic ischemia. Transplantation 1997, 64:821
128. Wanner GA, Muller P, Ertel W, et al: Differential effect of cyclooxygenase metabolites on proinflammatory cytokine release by Kupffer cells after liver ischemia and reperfusion. Am J Surg 1998, 175:146
129. Colletti LM, Kunkel SL, Walz A, et al: The role of cytokine networks in the local liver injury following hepatic ischemia/ reperfusion in the rat. Hepatology 1996, 23:506
130. Reinders ME, van Wagensveld BA, van Gulik TM, et al: No attenuation of ischemic and reperfusion injury in Kupffer cell-depleted, cold-preserved rat livers. Transplantation 1997, 63:449
131. Imamura H, Sutto F, Brault A, et al: Role of Kupffer cells in cold ischemia/reperfusion injury of rat liver. Gastroenterology 1995, 109:189
132. McCord JM, Fridovich I: The reduction of cytochrome-c by milk xanthine oxidase. J Biol Chem 1968, 243:5753
133. Granger DN, Rutili G, McCord JM: Superoxide radicals in feline intestinal ischemia. Gastroenterology 1981, 81:22
134. Freeman BA, Crapo JD: Biology of disease: Free radicals and tissue injury. Lab Invest 1982, 47:412
135. Jaeschke H: Reactive oxygen and ischemia/reperfusion injury of the liver. Chem Biol Interact 1991, 79:115
136. McCord JM: Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985, 312:159
137. Odlind B, Appelgren LE, Bayati A, et al: Tissue distribution of 125I-labelled bovine superoxide dismutase (SOD) in the rat. Pharmacol Toxicol 1988, 62:95
138. Atalla SL, Toledo-Pereyra LH, MacKenzie GH, et al: Influence of oxygen-derived free radical scavengers on ischemic livers. Transplantation 1985, 40:584
139. Romani F, Vertemati M, Frangi M, et al: Effect of superoxide dismutase on liver ischemia-reperfusion injury in the rat: A biochemical monitoring. Eur Surg Res 1988, 20:335
140. Cho WH, Kim DG, Murase N, et al: Comparison of superoxide dismutase, allopurinol, coenzyme Q10, and glutathione for the prevention of warm ischemic injury. Transplantation 1990, 50:353
141. Fujita T, Nishikawa M, Tamaki C, et al: Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono- and polysaccharide derrivatives. J Pharmacol Exp Ther 1992, 263:971
142. Kondo S, Segawa T, Tanaka K, et al: Mannosylated superoxide dismutase inhibits hepatic reperfusion injury in rats. J Surg Res 1996, 60:36
143. Mizoe A, Kondo S, Azuma T, et al: Preventive effects of superoxide dismutase derivatives modified with monosaccharides on reperfusion injury in rat liver transplantation. J Surg Res 1997, 73:160
144. Adkison D, Hollwarth ME, Benoit JN, et al: Role of free radicals in ischemia-reperfusion injury to the liver. Acta Physiol Scand Suppl 1986, 548:101
145. Vreugdenhil PK, Beizer FO, Southard JH: Effect of cold storage on tissue and cellular glutathione. Cryobiology 1991, 28:143
146. Marubayashi S, Dohi K, Yamada K, et al: Changes in the levels of endogenous coenzyme Q homologs, alpha-tocopherol, and glutathione in rat liver after hepatic ischemia and reperfusion, and the effect of pretreatment with coenzyme Q10. Biochim Biophys Acta 1984, 797:1
147. Bellomo G, Orrenius S: Altered thiol and calcium homeostasis in oxidative hepatocellular injury. Hepatology 1985, 5:876
148. Denno R, Takabayashi A, Sugano M, et al: The ratio of reduced glutathione/oxidized glutathione is maintained in the liver during short-term hepatic hypoxia. J Gastroenterol 1995, 30:338
149. Hahn R, Wendel A, Flohe L: The fate of extracellular glutathione in the rat. Biochim Biophys Acta 1978, 539:324
150. Ozaki M, Ozasa H, Fuchinoue S, et al: Protective effects of glycine and esterified gamma-glutamylcysteine on ischemia/ reoxygenation injury of rat liver. Transplantation 1994, 58:753
151. Suzuki H, Robinson MK, Rounds JD, et al: Glutathione deficiency accentuates hepatocellular fluid accumulation after ischemia-reperfusion. J Surg Res 1994, 57:632
152. Friedel HA, Goa KL, Benfield P: S-Ahenosyl-L-methionine: A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism. Drugs 1989, 38:389
153. Holdiness MR: Clinical pharmacokinetics of N-acetylcysteine. Clin Pharmacokinet 1991, 20:123
154. Dunne JB, Davenport M, Williams R, et al: Evidence that S-adenosylmethionine and N-acetylcysteine reduce injury from sequential cold and warm ischemia in the isolated perfused rat liver. Transplantation 1994, 57:1161
155. Fukuzawa K, Emre S, Senyuz O, et al: N-Acetylcysteine ameliorates reperfusion injury after warm hepatic ischemia. Transplantation 1995, 59:6
156. Koeppel TA, Lehmann TG, Thies JC, et al: Impact of N-acetylcysteine on the hepatic microcirculation after orthotopic liver transplantation. Transplantation 1996, 61:1397
157. Demir S, Inal-Erden M: Pentoxifylline and N-acetylcysteine in hepatic ischemia/reperfusion injury. Clin Chim Acta 1998, 275:127
158. Sumimoto K, Inagaki K, Ito H, et al: Ischemic damage prevention by coenzyne Q10 treatment of the donor before orthotopic liver transplantation: Biochemical and histologic findings. Surgery 1987, 102:821
159. Marubayashi S, Dohi K, Ochi K, et al: Role of free radicals in ischemic rat liver cell injury: Prevention of damage by alpha-tocopherol administration. Surgery 1986, 99:184
160. Gondolesi GE, Semplici AM, Luna GC, et al: Alpha-tocopherol reduces hepatocyte ischemia-reperfusion injury in an isolated rat liver model. Transplant Proc 1998, 30:2885
161. Yagi T, Sadamori H, Nakagawa H, et al: Hepatropic soluble vitamin E derivative EPC-K1 prevents warm ischemia/ reperfusion injury of non-heart-beating donor liver transplantation in pigs. Transplant Proc 1997, 29:1390
162. Auscher C, Amory N, Pasquier C, et al: Localization of xanthine oxidase activity in hepatic tissue. A new histochemical method. Adv Exp Med Biol 1977, 76A:605
163. Welbourn CRB, Goldman G, Paterson IS, et al: Pathophysiology of ischaemia reperfusion injury: Central role of the neutrophil. Br J Surg 1991, 78:651
164. McKelvey TG, Hollwarth ME, Granger DN, et al: Mechanisms of conversion of xanthine dehydrogenase to xanthine oxidase in ischemic rat liver and kidney. Am J Physiol 1988, 254:G753
165. Wiezorek JS, Brown DH, Kupperman DE, et al: Rapid conversion to high xanthine oxidase activity in viable Kupffer cells during hypoxia. J Clin Invest 1994, 94:2224
166. Nordstrom G, Seeman T, Hasselgren PO: Beneficial effect of allopurinol in liver ischemia. Surgery 1985, 97:679
167. Karwinski W, Soreide O: Allopurinol improves scavenging ability of the liver after ischemia/reperfusion injury. Liver 1997, 17:139
168. Nauta RJ, Tsimoyiannis E, Uribe M, et al: Oxygen-derived free radicals in hepatic ischemia and reperfusion injury in the rat. Surg Gynecol Obstet 1990, 171:120
169. Georgopoulos C, Welch WJ: Role of the major heat shock proteins as molecular chaperones. Ann Rev Cell Biol 1993, 9:601
170. DeNagel DC, Pierce SK: Heat shock proteins in immune responses. Crit Rev Immunol 1993, 13:71
171. Applegate LA, Luscher P, Tyrrell RM: Induction of heme oxygenase: A general response to oxidant stress in cultured mammalian cells. Cancer Res 1991, 51:974
172. Maines MD, Trakshel GM, Kutty RK: Characterization of two constitutive forms of rat liver microsomal heme oxygenase. J Biol Chem 1986, 261:411
173. Stocker R: Induction of haem oxygenase as a defence against oxidative stress. Free Radic Res Commun 1990, 9:101
174. Yachie A, Niida Y, Wada T, et al: Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999, 103:129
175. Amersi F, Buelow R, Kato H, et al: Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest 1999, 104:1631
176. Yamaguchi T, Horio F, Hashizume T, et al: Bilirubin is oxidized in rats treated with endotoxin and acts as a physiological antioxidant synergistically with ascorbic acid in vivo. Biochem Biophys Res Commun 1995, 214:11
177. Yamaguchi T, Terakado M, Horio F, et al: Role of bilirubin as an antioxidant in an ischemia-reperfusion model of rat liver and induction of heme oxygenase. Biochem Biophys Res Commun 1996, 223:129
178. Ito K, Ikeda S, Shibata T, et al: Immunohistochemical analysis of heme oxygenase-I in rat liver after ischemia. Biochem Mol Biol Int 1997, 43:551
179. Saad S, Kanai M, Awane M, et al: Protective effect of heat shock pretreatment with heat shock protein induction before hepatic warm ischemic injury caused by Pringle's maneuver. Surgery 1995, 118:510
180. Kume M, Yamamoto Y, Saad S, et al: Ischemic preconditioning of the liver in rats: Implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J Lab Clin Med 1996, 128:251
181. Yamagami K, Yamamoto Y, Kume M, et al: Heat shock preconditioning ameliorates liver injury following normothermic ischemia-reperfusion in steatotic rat livers. J Surg Res 1998, 79:47
182. Schoeniger LO, Andreoni KA, Ott GR, et al: Induction of heat-shock gene expression in postischemic pig liver depends on superoxide generation. Gastroenterology 1994, 106:177
183. Schutz E, Wieland E, Heine L, et al: Acceleration of hepatocellular energy by idebenone during early reperfusion after cold preservation ameliorates heat shock protein 70 gene expression in a pig liver model. Transplantation 1997, 64:901
184. Arora AS, Gores GJ: The role of metals in ischemia/ reperfusion injury of the liver. Semin Liver Dis 1996, 16:31
185. Omar R, Nomikos I, Piccorelli G, et al: Prevention of postischemic lipid peroxidation and liver cell injury by iron chelation. Gut 1989, 30:510
186. Colet J-M, Cetiner E, Hedlund BE, et al: Assessment of microvascular integrity in the isolated perfused rat liver by contrast-enhanced MRI. Attenuation of reperfusion injury by conjugated deferoxamine. Magn Reson Med 1996, 6:753
187. Colletti LM, Remick DG, Campbell DA Jr: Desferal attenuates TNF release following hepatic ischemia/reperfusion. J Surg Res 1994, 57:447
188. Amersi F, Dulkanchainun T, Nelson SK, et al: A novel iron chelator in combination with a P-selectin antagonist prevents ischemia/reperfusion injury in a rat liver model. Transplantation 1999 (submitted)
189. Braughler JM, Pregenzer JF, Chase RL, et al: Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation. J Biol Chem 1987, 262:10438
190. Killinger WA Jr, Dorofi DB, Keagy BA, et al: Improvement of endothelial cell viability at 4°C by addition of lazaroid U74500A to preservation solutions. Transplantation 1992, 53:983
191. Cosenza CA, Cramer DV, Cunneen SA, et al: Protective effect of the lazaroid U74006F in cold ischemia-reperfusion injury of the liver. Hepatology 1994, 19:418
192. Todo S, Hamada N, Zhu Y, et al: Lazaroid U-74389G for 48-hour canine liver preservation. Transplantation 1996, 61:189
193. Ishizaki N, Zhu Y, Zhang S, et al: Comparison of various lazaroid compounds for protection against ischemic liver injury. Transplantation 1997, 63:202
194. Palma-Vargas JM, Toledo AH, Garcia-Criado FJ, et al: 21-Aminosteroids block neutrophil infiltration and provide liver protection independent of NO2-/NO3-levels. J Surg Res 1996, 66:131
195. Weiss SJ: Tissue destruction by neutrophils. N Engl J Med 1989, 320:365
196. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, et al: Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation 1993, 55:1265
197. Jaeschke H, Farhood A, Smith CW: Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 1990, 4:3355
198. Kim YI, Akizuki S, Kawano K, et al: Intrahepatic neutrophil accumulation in ischemia/reperfusion injury of pig liver. Transplant Proc 1994, 26:2392
199. Jaeschke H, Farhood A, Bautista AP, et al: Functional inactivation of neutrophils with a MAC-1 (CD11b/CD18) monoclonal antibody protects against ischemia-reperfusion injury in rat liver. Hepatology 1993, 17:915
200. Mulligan MS, Polley MJ, Bayer RJ, et al: Neutrophil-dependent acute lung injury: Requirement for P-selectin (GMP-140). J Clin Invest 1992, 90:1600
201. Weyrich AS, Ma X-L, Lefer DJ, et al: In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest 1993, 91:2620
202. Misawa K, Toledo-Pereyra LH, Phillips ML, et al: Role of sialyl Lewis(x) in total hepatic ischemia and reperfusion. J Am Coll Surg 1996, 182:251
203. Dulkanchainun TS, Goss JA, Imagawa DK, et al: Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1. Ann Surg 1998, 227:832
204. Sako D, Chang X-J, Barone KM, et al: Expression cloning of a functional glycoprotein ligand for P-selectin. Cell 1993, 75:1179
205. Vachino G, Chang X-J, Veldman GM, et al: P-selectin glycoprotein ligand-1 is the major couner-receptor for P-selectin on stimulated T cells and is widely distributed in non-functional form on many lymphocytic cells. J Biol Chem 1995, 270:21966
206. Ming WJ, Bersani L, Mantovani A: Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J Immunol 1987, 138:1469
207. Colletti LM, Remick DG, Burtch GD, et al: Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 1990, 85:1936
208. Suzuki S, Toledo-Pereyra LH: Interleukin-1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury. J Surg Res 1994, 57:253
209. Shibuya H, Ohkohehi N, Tsukamoto S, et al: Tumor necrosis factor-induced, superoxide-mediated neutrophil accumulation in cold ischemic/reperfused rat liver. Hepatology 1997, 26:113
210. Klebanoff SJ, Vadas MA, Harlan JM, et al: Stimulation of neutrophils by tumor necrosis factor. J Immunol 1986, 136:4220
211. Nathan C, Srimal S, Farber C, et al: Cytokine-induced respiratory burst of human neutrophils: Dependence on extracellular matrix proteins and CD11/CD18 integrins. J Cell Biol 1989, 109:1341
212. Walcher F, Marzi I, Fischer R, et al: Platelet-activating factor is involved in the regulation of pathological leukocyte adhesion after liver transplantation. J Surg Res 1996, 61:244
213. Bautista AP, Spitzer JJ: Platelet-activating factor stimulates and primes the liver, Kupffer cells and neutrophils to release superoxide anion. Free Radic Res Commun 1992, 17:195
214. Read RA, Moore EE, Moore FA, et al: Platelet-activating factor-induced polymorphonuclear neutophil priming independent of CD11B adhesion. Surgery 1993, 114:308
215. Thornton AJ, Strieter RM, Lindley I, et al: Cytokine-induced gene expression of a neutrophil chemotactic factor/IL-8 in human hepatocytes. J Immunol 1990, 144:2609
216. Baggiolini M, Walz A, Kunkel SL: Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1989, 84:1045
217. Simonet WS, Hughes TM, Nguyen HQ et al: Long-term impaired neutrophil migration in mice overexpressing human interleukin-8. J Clin Invest 1994, 94:1310
218. Maher JJ, Scott MK, Saito JM, et al: Adenovirus-mediated expression of cytokine-induced neutrophil chemoattractant in rat liver induces a neutrophilic hepatitis. Hepatology 1997, 25:624
219. Matsushima K, Oppenheim JJ: Interleukin-8 and MCAF: Novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine 1989, 1:2
220. 4 in inflammation. Crit Rev Immunol 1990, 10:1
221. 4 in the pathogenesis of hepatic ischemia-reperfusion injury in the rat. Prostaglandins Leukot Essent Fatty Acids 1992, 45:113
222. Lentsch AB, Yoshidome H, Cheadle WG, et al: Chemokine involvement in hepatic ischemia/reperfusion injury in mice: Roles for macrophage inflammatory protein-2 and Kupffer cells. Hepatology 1998, 27:507
223. Rosales C, Juliano RL: Signal transduction by cell adhesion receptors in leukocytes. J Leukoc Biol 1995, 57:189
224. Wakelin MW, Sanz M-J, Dewar A, et al: An anti-platelet-endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through the basement membrane. J Exp Med 1996, 184:229
225. Suzuki S, Toledo-Pereyra LH: Monoclonal antibody to intercellular adhesion molecule 1 as an effective protection for liver ischemia and reperfusion injury. Transplant Proc 1993, 25:3325
226. Nakano H, Kuzume M, Namatame K, et al: Efficacy of intraportal injection of anti-ICAM-1 monoclonal antibody against liver cell injury following warm ischemia in the rat. Am J Surg 1995, 170:64
227. Marubayashi S, Oshiro Y, Maeda T, et al: Protective effect of monoclonal antibodies to adhesion molecules on rat liver ischemia-reperfusion injury. Surgery 1997, 122:45
228. Muller JM, Vollmar B, Menger MD: Pentoxifylline reduces venular leukocyte adherence ("reflow paradox") but not microvascular "no reflow" in hepatic ischemia/reperfusion. J Surg Res 1997, 71:1
229. Peng XX, Currin RT, Thurman RG, et al: Protection by pentoxifylline against normothermic liver ischemia/reperfusion in rats. Transplantation 1995, 59:1537
230. Nishizawa H, Egawa H, Inomata Y, et al: Efficiency of pentoxifylline in donor pretreatment in rat liver transplantation. J Surg Res 1997, 72:170
231. Vollmar B, Richter S, Menger MD: Liver ischemia/reperfusion induces an increase of microvascular leukocyte flux, but not heterogeneity of leukocyte trafficking. Liver 1997, 17:93
232. Jaeschke H, Smith CW: Mechanisms of neutrophil-induced parenchymal cell injury. J Leukoc Biol 1997, 61:647
233. Li XK, Matin AF, Suzuki H, et al: Effect of protease inhibitor on ischemia/reperfusion injury of the rat liver. Transplantation 1993, 56:1331
234. Nagendra AR, Mickelson JK, Smith CW: CD18 integrin and CD54-dependent neutrophil adhesion to cytokine-stimulated human hepatocytes. Am J Physiol 1997, 272:G408
235. Shappell SB, Toman C, Anderson DC, et al: MAC-1 (CD11/ CD18) mediates adherence-dependent hydrogen peroxide production by human and canine neutrophils. J Immunol 1990, 144:2702